Response to 'In-utero exposure to tenofovir is associated with impaired fetal and infant growth' by Denneman et al

AIDS. 2017 Feb 20;31(4):595-596. doi: 10.1097/QAD.0000000000001338.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anti-HIV Agents
  • Female
  • HIV Infections*
  • Humans
  • Infant
  • Pregnancy
  • Pregnancy Complications, Infectious
  • Prenatal Care
  • Tenofovir*

Substances

  • Anti-HIV Agents
  • Tenofovir